Yu Matsui

Yu Matsui

Auto-generated profile, based on publicly available information

Yu Matsui

Department of Dermatology, Faculty of Medicine Academic Assembly, University of Toyama Toyama Japan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2020 in The Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
YMYu Matsui
Yu Matsui
JSJin Sasaki
Jin Sasaki
STSumiko Takatsuka
Sumiko Takatsuka
TTTatsuya Takenouchi
Tatsuya Takenouchi

1 April 2020 in Burns Open
Verified
Journal Article
Open access
YMYu Matsui
Yu Matsui
TMTeruhiko Makino
Teruhiko Makino
KTKeita Takemoto
Keita Takemoto
KKKo Kagoyama
Ko Kagoyama
TSTadamichi Shimizu
Tadamichi Shimizu

9 April 2024 in The FASEB Journal
Verified
Journal Article
Closed access
PDF file
YMYu Matsui
Yu Matsui
AIAyako Imai
Ayako Imai
HIHironori Izumi
Hironori Izumi
MYMisato Yasumura
Misato Yasumura
TMTeruhiko Makino
Teruhiko Makino
TYTomoyuki Yoshida
Tomoyuki Yoshida

23 August 2025 in Photodermatology, Photoimmunology & Photomedicine
Verified
Journal Article
Closed access
YMYu Matsui
Yu Matsui
TSTadamichi Shimizu
Tadamichi Shimizu

7 May 2021 in The Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
YMYu Matsui
Yu Matsui
JSJin Sasaki
Jin Sasaki
STSumiko Takatsuka
Sumiko Takatsuka
TTTatsuya Takenouchi
Tatsuya Takenouchi

10 December 2025 in International Journal of Dermatology
Verified
Journal Article
Open access
JFJincong Q. Freeman
Jincong Q. Freeman
YMYu Matsui
Yu Matsui
FZFangyuan Zhao
Fangyuan Zhao
OOOlufunmilayo I. Olopade
Olufunmilayo I. Olopade
DHDezheng Huo
Dezheng Huo
Background: There is a lack of knowledge in full‐body skin examinations (FBSEs) in the context of pathogenic or likely pathogenic variants (PV/LPV) in skin cancer predisposition genes (CPGs). This study assessed the association between carrier status of PV/LPV in skin CPGs and FBSEs and described the patterns of family letter receipt, familial disclosure, and cascade testing among high‐risk individuals. Methods: Between July and September 2023, we surveyed participants enrolled in the Chicago Cancer Prone Study. Carrier status of PV/LPV in skin CPGs was defined as having been told by a genetic counselor that they have a PV/LPV in CDKN2A , TP53 , PTEN , BRIP1 , PALB2 , ATM , and/or CHEK2 genes. FBSEs were assessed by asking individuals whether they ever had an FBSE and modeled using logistic regression. Results: Of 579 individuals (mean age, 59.5 years), 11.6% carry PV/LPV in skin CPGs and 63.8% ever had a FBSE. Carriers had greater odds of FBSEs than non‐carriers (adjusted odds ratio, 2.15; 95% CI, 1.03–4.52). White race, older age, and female sex were associated with increased odds of FBSEs. Among carriers, 65.3% received a family letter from their genetic counselor after testing; 91.0% disclosed their PV/LPV‐carrying status to any family members, and 62.7% of the individuals' family members underwent genetic testing. Conclusions: We found greater odds of FBSEs among PV/LPV carriers, notable disparities in FBSEs, and prevalent family letter receipt, familial disclosure, and cascade testing. This study highlights the role of PV/LPV‐carrying status on FBSEs and the potential need for comprehensive guidelines beyond known risk factors to optimize skin cancer screening in high‐risk populations.